Healthcare Contract Manufacturing Market- Latest trends, Industry Updates and Regional Forecast to 2023

Overview:

The healthcare contract manufacturing market is benefiting much from the growing demand for medicine supplies which is facing a severe crisis from the pending expiration of a lot of generic drugs. The market relies heavily on the outsourcing of the manufacturing process of drugs to contract manufacturers. From drug development to drug manufacturing, a comprehensive platform this healthcare contract manufacturing sector provides. The from drug development to drug manufacturing market is expecting a growth by 9.86% during the forecast period (2017-2023), claims Market Research Future (MRFR). The report ensures a detailed analysis of the segments and driving factors that can assist the market in growth over the review period.

Among the factors, patent expiration of several drugs can be deemed as one of the chief influencers that can foster the market growth during the forecast period. Emerging economies are demanding for greater percolation as the population boom in those countries have created scope for substantial market expansion. Drug manufacturers are also looking for significant contribution from these companies as number of drugs in the pipeline is getting piled up. Factors such as these are bound to boost the global from drug development to drug manufacturing market.

On the flip side, controlling third parties is quite complex which many manufacturers prefer to avoid. At the same time, clinical trials are becoming more exhaustive and tangled which can deter the healthcare contract manufacturing market from having the expected growth rate over the review period.

Segmentation:

The global healthcare contract manufacturing market can be segmented by type, service type, and industry.

Based on the type, the healthcare contract manufacturing market can be segmented into sterile and non-sterile.

On the basis of the service type, the healthcare contract manufacturing market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.

Industry-wise segmentation of the healthcare contract manufacturing market includes pharmaceutical, medical device, and biopharmaceutical.

Regional Analysis:

Region-specific analysis of the global healthcare contract manufacturing market includes the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas is in charge of the global healthcare contract manufacturing market. With rising investment in healthcare, the focus is mainly on improving healthcare infrastructure and upgrading research institutions for better technology and others. Subsequently, manufacturers are now relying more on the advanced instruments they have put in use in their factories and manufacturing capabilities.

Europe assumes the second position in the market and the credit goes to the increased expenditure initiated by the regional governments. The reports published by the Organization for Economic Co-operation and Development (OECD) discloses that Germany spent USD 321 billion in 2014 in the healthcare sector which is a significant marker of the progress the regional market is making at present.

The APAC is the fastest growing market as major regional economies such as China and India are considerably investing to better their healthcare facilities to lure in patients from all over the world as a part of their medical tourism planning.

Competitive Analysis:

Some of the key players in this healthcare contract manufacturing market are Aesica Pharmaceuticals, Boehringer Ingelheim, AbbVie, Grifols International, S.A, Evonik Industries, Lonza Ag, Catalent, Benchmark Electronics, Flex Ltd, Forefront Medical Technologies, Hamilton Company, Sanmina Corporation, Teva Pharmaceutical Industries, Patheon, Mylan, Vetter Pharma International, and others.

In August 2018, Catalent completed their move to acquire Juniper. This would give the former a new and robust European base to function. Catalent, as the parent company of Juniper, would ensure the supply of Crinone marketed by Merck KGaA.

In January 2018, Intermountain Healthcare declared their plan to create a non-profit generic drug company as a direct manufacturer or contract manufacturer in collaboration with Ascension, SSM Health, and Trinity Health.

You can See More Report :

Forensic Swab Market Research Report - Global Forecast to 2023

Intravenous (IV) Solution Market Research Report - Global Forecast till 2022

Cardiac Implants Market Research Report - Forecast to 2023 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Cystic Fibrosis (CF) Therapeutics Market Outlook 2020 | Global Industry Growth & Demand by 2025

Cystic Fibrosis (CF) Therapeutics Market Overview: 

Cystic fibrosis is a genetic disorder that commonly affects the lungs and also the other secretory glands such as pancreas, liver, kidneys and intestine. As per the report that has been published by Market Research future (MRFR), the global cystic fibrosis market is anticipated to expand significantly at a CAGR of 13.5% during the forecast period of 2016-2022.

Market Drivers and Restraints: 

The incidences of diseases caused due to genetic disorders owing to mutation in human genes are increasing rapidly. The prevalence of such diseases is generating high demand for effective treatments. Increased research and development activities in order to introduce new drugs and highly effective treatments for cystic fibrosis owing to the high prevalence of this disease is leading to the significant growth of the global cystic fibrosis market.

Development of various diagnostic tests to detect genetically inherited cystic fibrosis and high investment in R&D are projecting positive impact on the expansion of the global cystic fibrosis market. Initiatives such as newborn screening programs to diagnose cystic fibrosis at young age and introduction of new drugs with higher efficacy are fueling the growth of the global Cystic Fibrosis (CF) Therapeutics Market.

However, increase in the complexity of disease and high cost of treatment along with lack of awareness are likely to impact negatively on the growth of the global cystic fibrosis market during the forecast period. 

Market Segmentation:

The global cystic fibrosis market has been segmented on the basis of treatment. Based on treatment, the cystic fibrosis market is segmented into medication, devices and other treatments. The medication segment accounts for the largest share of 76.4% in the global cystic fibrosis market owing to the high demand of efficient medication to treat cystic fibrosis and increased research for developing new drugs by the medical institutes and pharmaceutical companies in the global market.

Regional Analysis:

The global cystic fibrosis market is geographically segmented into North America, Europe, Asia Pacific and the Middle East and Africa. The North America region is dominating the global cystic fibrosis market owing to the high prevalence of cystic fibrosis in this region.

Increasing incidences of cystic fibrosis and rise in demand for proper treatment are driving the cystic fibrosis market in the Europe region. The Asia Pacific region is projecting steady growth in the global cystic fibrosis market owing to the low prevalence of this disease in this region.

The Middle East and Africa region accounts for the least share in the global cystic fibrosis market owing to the lack of awareness and poor healthcare facilities in the underdeveloped area of this region. 

Industry Updates:

In August 2018, an independent advisory committee by the Federal government has announced that a new drug, Orkambi, will soon be subsidized and listed on the Pharmaceutical Benefits Scheme and will be made available for public use. 

Key Players:

Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, Genentech, Pharmaxis, Chiesi Farmaceutici, Forest Laboratories and others.     

Read More @ https://www.marketresearchfuture.com/reports/cystic-fibrosis-market-1825

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Effective Results of Acupuncture and Drug Delivery Is Projected to Create Lucrative Growth Prospects

Market Insights

The arrival of technically advanced acupuncture treatments, such as the use of laser and electroacupuncture equipment, is expected to improve the development of the acupuncture market internationally over the anticipated period, asserts Market Research Future (MRFR) in its latest report.

Market growth is fueled by factors such as the increasing incidence of gynecological conditions such as, pregnancy problems premenstrual syndrome, polycystic ovary syndrome (PCOS), menstrual problems, menopause, infertility, and chronic pain disorders. In addition, the increasing frequency of chronic diseases such as fibromyalgia and migraine, leading to health complications such as insomnia, body aches, and mental disorders, will stimulate the progress of the acupuncture market.

In addition, many notable competitors are involved in the development and production of laser and electro-acupuncture equipment. The growing number of health problems in the elderly, such as sleep disorders, body, and pain, also fueled the development of the market. The rising geriatric population worldwide is expected to affect the acupuncture market during the forecast period. Growing demand for alternative and complementary drugs, such as acupuncture, has strengthened the market financing landscape, which may be an important opportunity for market expansion over the forecast period. Financing from competitors and newcomers to the market is likely to contribute to market growth over the forecast period.

Market Segmentation

The acupuncture market is segmented based on application, end-user, and product and services.

The global acupuncture market is diversified on the basis of products and services. The service segment also includes Japanese acupuncture, cupping, traditional Chinese medicine, auricular, Korean hand acupuncture, moxibustion scalp acupuncture, non-insertion acupuncture, and others. The product segment is also segmented into suction cups, needles, rod lasers, laser needle, and laser pens, electro-acupuncture devices, and more. The needles are subdivided into traditional and modern needles.

The application segment of the global market is classified into gynecological disorders, pain syndrome disorders, mental illness, and others. Pain syndrome diseases dominate the market with largest share of 33.5%.

The end-user segment of the market is segmented into specialized hospitals and clinics, wellness centers, and academic and research institutions. The wellness center is predicted to influence the global acupuncture market due to a large number of wellness centers involved in acupuncture therapies and the growing preference for acupuncture as alternative medicine.

Regional Outlook

Regional market analysis indicates that the European region should dominate with the largest share of the global acupuncture market and should grow with a 13.53% CAGR over the forecast period. The development of the market is related to the growing number of chronic diseases and the growing preference for acupuncture treatments among the European population. In addition, the existence of major competitors in the market contributes significantly to market growth in the region. In addition, increasing insurance coverage in countries such as Austria, France, Spain, and other private companies will provide promising results in market growth in the European region.

The Asia Pacific region is probably the fastest-growing region in the acupuncture market in the world and is predicted to spur with a compound annual growth rate of 15.02% during the assessment year. In addition, the growing number of companies producing acupuncture products and the increasing prevalence of chronic diseases are leading the market growth in this region.

Market Participants

The players involved in manufacturing the necessary devices and equipments both, traditional and modern include 3B Scientific GmbH, Asia med GmbH, Qingdao Great Fortune Co. Ltd, Zepter International, AcuMedic Ltd, Kanson, SEIRIN Corporation, MKW Lasersystem GmbH, Cymedics GmbH & Co. KG, schwa-medico GmbH, and Wuxi Jiajian Medical Instruments Co.

Recent Updates

In a study performed by the researchers from South Medical University, the drug therapy and acupuncture were combined while treating the patients. The combinational outcome of the acupuncture and drug were fruitful in contrast to patients who were treated only with drug injections.

Read More@ https://www.marketresearchfuture.com/reports/acupuncture-market-6139

Latest Trending Report@

Aromatherapy Market Research Report- Global Forecast To 2023

Medical Marijuana Market Global Research Report - Forecast till 2023

Unnatural Amino Acids Market is expected to register 12.01% CAGR and reach USD 9,454.1 million till 2023

Market Highlights

Based on the present trends, it may be safely assumed that many biotechnology and pharmaceutical companies will now give more attention to peptide drugs and research on them. This trend is partly due to the fact that both patients and physicians are now accepting and acknowledging the benefits from proteinaceous therapeutics. Scientists have also come up with solutions to the shelf life period of peptide drugs, and delivery problems related to them.

The global unnatural amino acids market is expected to grow at a CAGR of 12.01% during the forecast period 2017-2023.

Taste the market data and market information presented through more than 210 market data tables and figures spread over 187 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “unnatural amino acids market research report–Global forecast till 2023.”

Segmentation

The global unnatural amino acids market share is segmented on the basis of types, application, and end user. On the basis the types, it is segmented into D-phenylalanine, D-histidine, D-tyrosine, D-serine, D-alanine, D-tryptophan, D-cysteine, D-phenylglycine, D-p-hydroxy phenylglycine, D-2-chlorophenylglycine, D-penicillamine, D- proline, D-valine, D-citrulline /D-citrulene, D-lysine, D-leucine, D-glutamic acid, D-methionine, D-aspartic acid, D-arginine, D-cycloserine, and others. On the basis of the application, it is segmented into liver diseases, cancer, inflammatory disease, genetic diseases, and others. On the basis of end user it is segmented into pharmaceutical & biotechnological companies, research laboratories, academic institutes, and others.

Table Of Contents

TABLE 1 PRIMARY INTERVIEWS 21

TABLE 2 GLOBAL UNNATURAL AMINO ACIDS MARKET FOR D-AMINO ACIDS & DERIVATIVES, BY REGION, 2014–2023 (USD MILLION) 38

TABLE 3 GLOBAL UNNATURAL AMINO ACIDS MARKET FOR DL-AMINO ACIDS & DERIVATIVES, BY REGION, 2014–2023 (USD MILLION) 38

TABLE 4 GLOBAL UNNATURAL AMINO ACIDS MARKET FOR Β-AMINO ACIDS & DERIVATIVES, BY REGION, 2014–2023 (USD MILLION) 39

TABLE 5 GLOBAL UNNATURAL AMINO ACIDS MARKET FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY REGION, 2014–2023 (USD MILLION) 39

TABLE 6 GLOBAL UNNATURAL AMINO ACIDS MARKET FOR L-AMINO ACID DERIVATIVES, BY REGION, 2014–2023 (USD MILLION) 40

TABLE 7 GLOBAL UNNATURAL AMINO ACIDS MARKET FOR GAMMA-AMINO BUTYRIC ACID, BY REGION, 2014–2023 (USD MILLION) 40

TABLE 8 GLOBAL UNNATURAL AMINO ACIDS MARKET FOR GAMMA-AMINO-BETA- HYDROXYBUTYRIC ACID, BY REGION, 2014–2023 (USD MILLION) 41

ACCESS REPORT DETAILS @ https://www.marketresearchfuture.com/reports/unnatural-amino-acids-market-4909

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Dietary Supplements In The Age Of Personalized Nutrition Market Size, Regional Outlook, Competitive Strategies and Forecasts

Dietary Supplements in the Age of Personalized Nutrition Market Information: Product Category (Vitamins, Herbs & Botanicals, Others), Application (Lifestyle Diseases, Inherited Disease and Others), Gender, Dosage Form (Tablets, Capsules, Others) and End-User – Global Forecast Till 2023

Market Synopsis:

Market Research Future (MRFR) has published a report stating that the global dietary supplements in teh age of personalized nutrition market is anticipated to expand moderately at a CAGR of 6.90% during the forecast period of 2017-2023. Increasing awareness regarding the necessity of nutrients in daily diet and rise in popularity of fitness programs are primarily propelling the expansion of the global dietary supplements in the age of personalized nutrition market. Increasing incorporation of technologically advanced research and manufacturing processes in the pharmaceutical and healthcare industry along with the high demand for personalized medication are also fueling the growth of the global dietary supplements in the age of personalized nutrition market. However, concerns regarding the side effects cause by these supplements are likely to act as restraining factors for the growth of the global dietary supplements in the age of personalized nutrition market during the forecast period.

Regional Analysis:

The global dietary supplements in the age of personalized nutrition market has been geographically segmented into four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa. Among these, the Americas command for the major share in the global dietary supplements in teh age of personalized nutrition market owing to the presence of leading manufacturers, high healthcare expenditure by the population of this region and utilization of advanced technology for the production of personalized drugs and supplements in this region. Increased research in the nutrition industry for the development of personalized dietary supplements by studying the DNA, dietary habits and other factors in an individual is majorly propelling the expansion of teh dietary supplements in the age of personalized nutrition market. Improving economic conditions, increasing geriatric population, government support for research and development in teh healthcare sector and rise in awareness regarding the health benefits of dietary supplements are boosting the dietary supplements in the age of personalized drugs market in the Asia Pacific region. Whereas, low penetration of proper healthcare services and lack of awareness among the population of the underdeveloped regions are leading to the slow growth of the dietary supplements in the age of personalized nutrition market in the Middle East and Africa market.

Market Segmentation:

The global dietary supplements in the age of personalized nutrition market has been segmented on the basis of product category, gender, application, dosage form and end user. Based on product category, the market has been segmented into vitamins, herbs & botanicals, sports supplements, meal supplements, minerals and other. Based on application, the market has been segmented into lifestyle diseases, inherited diseases, genetic predispositions and others. Based on gender, the market has been segmented into female and male. The female segment has been sub-segmented into 55 + age group, 35-54 age group, 19-34 age group, and 0-18 age group. The male segment has also been sub-segmented into 55 + age group, 35-54 age group, 19-34 age group, and 0-18 age group. Based on dosage form, the market has been segmented into tablets, capsules, powder, liquids, soft gels and others. Based on end users, the market has been segmented into hospitals & clinics, home care, and others.

Industry Updates:

In October 2018, Persona, a leading personalized vitamin program, has announced the launch of its new nutritional supplements that are specially designed to support healthy sleep pattern and healthy hair, nails and skin.

In September 2018, Nestlé has announced the that it is piloting a new personalized nutrition program in Japan named "Wellness Ambassador", which combines DNA testing, artificial intelligence and meal analysis to collect consumer data on diet and health.

Key Players:

The major players profiled by MRFR that are operating in the global dietary supplements in the age of personalized nutrition market are Nestlé Health Science, Danone Nutricia, Carlyle Group, Amway (Nutrilite), Archer Daniels Midland, Abbott Laboratories, Herbalife International, Amway, Danisco, Glanbia, Bayer AG, GlaxoSmithKline plc, Pfizer Inc., Balchem Corporation, Natures Product Inc., Bactolac Pharmaceutical Inc. and others.

Read More @ https://www.marketresearchfuture.com/reports/global-dietary-supplements-market-5703

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Global Emergency Department Information System (EDIS) Market Insights and In-Depth Analysis 2019 Meditech, Epic Systems Corporation, Cerner, Mckesson Corporation, and Medhost

Emergency department information systems are EHR systems, or electronic health record systems, that are specifically designed for managing data and workflow. This is done so as to support emergency department patient care and operations. The global emergency department information system market is anticipated to garner a CAGR of 15.10% during the assessment period between 2017 and 2023.

The global emergency department information systems market is identified to be driven by the increasing rate of aging population, rising demand for data-driven technologies, an increasing number of hospitals, growing emergency department visits, and rising coverage in insurance. Over the years, a rising percentage of hospitals have incepted due to the imperative need for advanced, clinical, and timely form of treatment. This rise in the number of hospitals across both developing and developed nations is believed to be a major growth factor for the global market of emergency department information systems.

Market Segmentation

The global Emergency Department Information System (EDIS) Market segmentation is divided into end-user, application, component, and delivery mode.

By component, the market includes hardware, software, and services. The software segment is narrowed down into enterprise solutions and best-of-breed solutions. In this market segment, software holds the largest market share and is expected to attain a CAGR of 15.39% during the review period of 2017 to 2023.

By application, the market divides into administrative functionalities and clinical functionalities.

By delivery mode, the market includes on-premise and software-as-a-service (SaaS). The SaaS segment holds the maximum share percentage in this market segmentation and is projected to witness a CAGR of 15.33% during the assessment period.

By end-users, the market comprises of medium-sized hospitals, large hospitals, and smaller-scale hospitals. The large hospitals segment hold the primal spot in terms of market portion with close to half of the share to its name.

Regional Analysis

The global emergency department information system market is regionally segmented into four key regions, namely Asia Pacific, Europe, Americas, and the Middle East & Africa.

The Americas region hold the top-spot in terms of market with about 38.6% of the share to its name as per the published report of 2016. The majority percentage of the market can be attributed to the presence of various major-level manufacturers, technological advancements, and high rate of adoption for emergency department information systems. Europe stands as the second-largest market in global standings and acts as a significant contributor to the overall emergency department information system market.

The Asia Pacific region is expected to be the fastest growing market globally with a projected CAGR of 15.71% during the forecast period. The regional market holds unmatched opportunities and boasts of continuously growing economies. Herein, factors driving the market are improving economies, latest healthcare developments, a growing percentage of public and private hospitals, and others. The Middle East & African market holds the least market share and is expected to grow at a slow pace in the forthcoming years of the forecast period due to lack of economic development and highly low level of income.

Competitive Landscape

The global emergency department information system market boasts a number of key players under its umbrella. The market players are pushing the boundaries of innovation and placing focus on research and development activities to boost the overall market growth and demand. Some of the leading players identified in this market are Evident, Medical Information Technology, Inc, Cerner Corporation, Mckesson Corporation, Medhost Inc, Siemens Healthcare, Logibec Canada, T-System Inc, Allscripts, EPOWERdoc, Inc, Unitedhealth Group, Epic Systems, Inc, Healthland, Inc, veEDIS Clinical Systems LLC, and Wellsoft.

Industry News

Feb 28^th, 2019, Medsphere, a healthcare IT solution provider, announced in a release that it has acquired Wellsoft Corporation, a company specializing in emergency department information system. The motive behind the acquisition centers around Medsphere’s plan of launching a solution for urgent care centers.

Jan 9^th, 2019, Document Storage Systems (DSS), announced in a statement that it has finalized on acquiring the Emergency Department Information System software from a pioneering EDIS company named veEDIS Clinical Systems.

Read More @ https://www.marketresearchfuture.com/reports/emergency-department-information-system-market-5926

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Kidney Stone Management Devices Market: Development History, Current Analysis and Estimated Forecast to 2025

Market Synopsis:

The changes in lifestyle have led to a drastic increase in the patient population of urolithiasis. This, in turn, has led to rapid developments in technology and diagnosis. Market Research Future (MRFR) has asserted in its latest study that the global kidney stone market is expected to expand at a moderate CAGR over the projection period 2017 to 2022. Technological innovations are poised to dictate the growth trajectory of the market in the years to come.

The introduction of minimally invasive procedures has revolutionized the growth pattern of the healthcare sector. A similar trend is likely to positively influence the expansion of the kidney stone management devices market over the next couple of years. The advancements in the diagnosis of kidney stones through minimally invasive procedures is expected to boost the revenue generation of the market across the review period.

The large-scale prevalence of the chronic disease, diabetes, is anticipated to affect a larger fraction of the population in the foreseeable future. Thus, the kidney stone market is projected to remain highly lucrative over the next few years. However, the adverse effects of extracorporeal shock wave lithotripsy can pose a challenge to the market players.

Market Segmentation:

By type, the global kidney stone market has been segmented into uric acid, calcium stones, struvite kidney stones, and cystine stones. Among these, the calcium stones segment has gained higher traction of the market and is anticipated to retain its dominance over the next few years.

On the basis of treatment, the kidney stone market has been segmented into medications, ureteroscopy (URS), extracorporeal shock wave lithotripsy (ESWL), and percutaneous nephrolithotomy (PCNL). The ureteroscopy (URS) segment is likely to generate relatively higher revenue as it is preferred by the patients over other methods.

The global kidney stone market, by diagnosis, has been segmented into intravenous pyelography (IVP) or intravenous urogram, ultrasound, CT scan, and X-ray. Among these, the ultrasound segment is anticipated to hold the pole position in the market and grow substantially over the assessment period. The process doesn’t use radiation which is anticipated to support the growth pattern of the segment.

Regional Analysis:

By region, the global kidney stone market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). North America is currently leading the growth of the global market. It is anticipated to retain its prominence over the assessment period. Europe is at the second spot and is likely to grow leaps and bounds during the review period. On the other hand, Asia Pacific is projected to exhibit significant growth owing to the presence of fast-developing economies such as India, China, etc.

Competitive Dashboard:

The prominent players operating in the global kidney stone market are EDirexGroup (Israel), Boston Scientific Corp. (U.S.), .M.S. Electro Medical Systems S.A. (Switzerland), Elmed Electronics & Medical Industry & Trade Inc. (Turkey), Convergent Laser Technologies (U.S.), Medispec Ltd. (U.S.), C.R. Bard Inc. (U.S.), Dornier MedTech GmbH (Germany), Cook Medical Inc. (U.S.), Richard Wolf GmbH (Germany), Stryker Corp. (U.S.), STORZ MEDICAL AG (Switzerland), Siemens Ltd. (Germany), and Olympus Corp. (Japan).

Industry News:

In April 2019, Dornier MedTech (Dornier), a leader in kidney stone management, announced the launch of AXIS™ Single-Use Digital Flexible Ureteroscope (AXIS™) along with Stone Management Products for the U.S. market.

In December 2018, Shockwave Medical, a pioneer in urologic lithotripsy for breaking up kidney stones, has collaborated with Abiomed Inc., a medical device company, for the complementary use of their respective technologies.

In July 2018, a global leader in innovative kidney stone management, Dornier MedTech (Dornier), has introduced a new laser portfolio for the Singapore market which comprises of Dornier Medilas H 140 and Dornier Medilas H Solvo 35 for urological stones.

Read More @ https://www.marketresearchfuture.com/reports/kidney-stones-market-1745

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com